In breast cancer models, ICIs activate CD8+ T cells, inducing tumor vessel normalization, which alleviates TME immunosuppression, enhancing T cell infiltration and cytotoxicity—a positive feedback loop underpinning ICI combinations (158). This evidence concerns the gene CD8A and neoplasm.